Drugs / Ga68-DOTA-TATE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03125629 | May 2014 → Nov 2016 | — | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ga68-DOTA-TATE | “Patients receive standard of care 18F-fludeoxyglucose (FDG) or Ga68-DOTA-TATE intravenously (IV).” NCT03125629 ↗ |
| Known as | 68Ga-DOTA-TATE | “68Ga-DOTA-TATE PET/CT Scan” NCT03125629 ↗ |